Experimenter at tissue culture hood MI-mAbs

MI-mAbs accelerates Immuno Oncology discovery

Interview by Pieter Droppert, Biotech Strategy Blog Author

Excerpt of Biotech Strategy Blog interview with Professor François Romagné, Scientific Director of MI-mAbs, a drug discovery research center focused on new monoclonal antibodies for the treatment of cancer and inflammatory diseases.

Listen

  Back